Drug eluting stents are liberally used worldover .
It is very unfortunate ,while the jury is still confused about the role of DES “even” in chronic coronary syndrome ,
There has been widespread use of DES in the potentially hazardous thrombotic milieu of STEMI . It is well known the DES ( polymer and drug) has a dangerous liaison with the thrombus.
Even as the evidence base was about to accumulate against the DES in STEMI , there was an undue haste in the use of this stent in STEMI .
Now in 2010 the results are out the DEDICATION trial
- The culprit is out
- The truth exposed
- DES kills more life than bare metal stents during primary PCI
Read this article ,just released in Atlanta 2010
http://www.cardiosource.com/clinicaltrials/trial.asp?trialID=1618
Dr.S.Venkatesan MD 